PDC and pancreatic adenocarcinoma: In PAAD, therapeutic sensitivity may be impacted by molecular subtype so the Moffitt molecular classification system was employed to analyze transcriptomic data derived from each PDC, as this classification system is not influenced by stromal components (37–39).